Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Induction of apoptosis and cell growth inhibition by protein 4.33

a technology of cell growth inhibition and apoptosis, which is applied in the field of induction of apoptosis and cell growth inhibition by protein 4.33, can solve the problems of inability to predict the nature, size, number, absolute specificity or complexity of such postulated cell surface association proteins, and cannot be fully understood

Inactive Publication Date: 2010-05-13
OREGON HEALTH & SCI UNIV
View PDF13 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, nothing is known about the nature, size, number, absolute specificity or complexity of such postulated cell surface association proteins, and no such protein has ever been cloned, purified, or otherwise characterized to provide any information whatsoever as to the actual functional involvement or sufficiency of such proteins for specific cell surface IGFBP-3 binding, or for IGFBP-3 mediated, IGF-independent biological action.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Induction of apoptosis and cell growth inhibition by protein 4.33
  • Induction of apoptosis and cell growth inhibition by protein 4.33
  • Induction of apoptosis and cell growth inhibition by protein 4.33

Examples

Experimental program
Comparison scheme
Effect test

example 1

Cloning of a cDNA for a Novel IGFBP-3 Interacting Protein, P4.33

[0192]The following example of the present invention describes the cloning and isolation of clone 4.33, a cDNA encoding a novel IGFBP-3 interacting protein. The results show the discovery of a novel cDNA, 915 by in length (SEQ ID NO:1), encoding a novel 240 amino acid protein (SEQ ID NO:2) that contains several N-glycosylation sites, a cAMP-dependent phosphorylation site, a single leucine-zipper motif (LZ), and a putative transmembrane domain near the C-terminus. See FIG. 2C.

Material and Methods

[0193]Yeast two-hybrid screen. An Hs578T cDNA library in pGAD10 was generated using the Two-Hybrid cDNA Library Construction Kit (Clontech). The “bait” plasmid was constructed by amplifying an internal sequence of the IGFBP-3 cDNA (encoding amino acids 88-148) by PCR, then cloning this fragment into the pBTM116 vector, in frame with the LexA DNA binding domain coding sequence. The bait plasmid was then transformed into yeast stra...

example 2

Cellular Localization of EGFP::4.33 Fusion Protein, and Cellular Colocalization and Co-Immunoprecipitation of IGFBP-3 and Clone 4.33

[0202]According to the present invention, the interaction between IGFBP-3 and clone 4.33 was confirmed by immunocytochemistry (FIG. 3A) and in coimmunoprecipitation studies (FIG. 3B). COS-7 cells were transiently transfected with or without constructs encoding an EGFP::4.33 fusion protein and FLAG-tagged IGFBP-3 (IGFBP-3F).

Material and Methods

[0203]Immunocytochemistry. Cells were seeded in 8-chamber culture slides (Nunc) and transfected at 70-80% confluency. After 48 hours, adherent cells were washed with PBS, fixed in 4% paraformaldehyde for 10 minutes at room temperature, and washed a further 3 times with PBS. Cells were then incubated in blocking solution (1% normal goat serum in PBS, 0.1% Triton X-100) for 1 hour at room temperature, followed by incubation with primary antibody diluted 1:1000 in blocking solution for 1-2 hours at room temperature. C...

example 3

Cellular Overexpression of Clone 4.33 Resulted in Increased Specific IGFBP-3 Cell-Surface Binding, and Co-Translocation to the Nucleus

[0212]According to the present invention, the binding of 125I-labelled IGFBP-3 to cells previously transfected with clone 4.33 was measured to determine whether the resulting expressed P4.33 could facilitate specific binding of IGFBP-3 to the cells (FIG. 4A).

Material and Methods

[0213]Cell culture, transfection, cell lysates, membrane preps. All cell lines, except the MCF-7:BP-3 stable lines, were purchased from ATCC. All were cultured in DMEM / high glucose with 10% fetal bovine serum. MCF-7:BP-3 stable lines were generated from wild type MCF-7 cells using the Ecdysone-inducible expression system (Invitrogen) according to the manufacturers instructions, and were maintained in DMEM / high glucose, 10% fetal bovine serum with 100 μg / mL Zeocin+800 μg / mL G418. IGFBP-3 protein production was induced with the addition of ponasterone A (Invitrogen) to the cultur...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
pHaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

There is disclosed an isolated cDNA sequence (SEQ ID NO:1) encoding a P4.33 polypeptide and comprising a coding region (SEQ ID NO:2) of the sequence described in SEQ ID NO:1, or a sequence having at least 90% homology with the coding region of SEQ ID NO:1. The P4.33 polypeptide functions as a specific cell-surface receptor for IGFBP-3, and undergoes nuclear translocation in combination with IGFBP-3. In particular aspects, IGFBP-3 and P4.33 (IGFBP-3R) cooperatively suppress DNA synthesis and cell growth, and induce caspase activation and apoptosis in cancer cells, indicating that P4.33 is an important mediator of IGF-independent growth inhibitory actions of IGFBP-3. The P4.33:IGFBP-3 system of the present invention can be used, inter alia, in screening and diagnostic assays, and for therapeutic methods for cancer treatment and tumor suppression.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of U.S. patent application Ser. No. 10 / 276,491, filed 20 Feb. 2003 and entitled INDUCTION OF APOPTOSIS AND CELL GROWTH INHIBITION BY PROTEIN 4.33, which is the United States nationalization, under 35 U.S.C. §371, of PCT / US01 / 16437, filed 17 May 2001 of same title, which claims the benefit of priority to U.S. Provisional Patent Application Ser. No. 60 / 204,949, filed 17 May 2000 of same title, all of which are incorporated herein by reference in their entirety.STATEMENT REGARDING FEDERALLY-SPONSORED RESEARCH[0002]This work was supported by Department of Defense grant 17-96-1-6304 and 17-97-1-7204. The United States has certain rights in this invention, pursuant to 35 U.S.C. §202(c)(6).TECHNICAL FIELD OF THE INVENTION[0003]Aspects of the present invention relate to drug candidate screening assays, diagnostic and therapeutic methods for the treatment of cancer, and tumor suppression, utilizing a novel IGFBP-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N5/10C07H21/04C12N15/63C07K14/47C07K16/00A61K38/00A61P35/00A61P43/00C07K14/705C12N15/11
CPCA61K38/00C07K14/705C07K14/4747A61P35/00A61P43/00
Inventor OH, YOUNGMANROSENFELD, RON G.INGERMANN, ANGELA RANAE
Owner OREGON HEALTH & SCI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com